News
STLN
6.63
+7.28%
0.45
Cedar Grove Capital Q3 2026 Portfolio Update
Seeking Alpha · 3d ago
Starling Oncology management to meet with B. Riley
TipRanks · 4d ago
Starling Oncology management to meet with Needham
TipRanks · 4d ago
Weekly Report: what happened at STLN last week (0928-1002)?
Weekly Report · 5d ago
Starling Oncology: Improving Cash Flow And Gross Profit Fuel A Re-Rating
Seeking Alpha · 09/30 13:32
Weekly Report: what happened at STLN last week (0921-0925)?
Weekly Report · 09/28 10:12
Weekly Report: what happened at STLN last week (0914-0918)?
Weekly Report · 09/21 10:12
Weekly Report: what happened at STLN last week (0907-0911)?
Weekly Report · 09/14 10:17
Weekly Report: what happened at STLN last week (0831-0904)?
Weekly Report · 09/07 10:11
Starling Oncology Announces Governance Transition as Director Steps Down
TipRanks · 09/02 10:31
Weekly Report: what happened at STLN last week (0824-0828)?
Weekly Report · 08/31 10:18
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 08/28 21:06
Weekly Report: what happened at STLN last week (0817-0821)?
Weekly Report · 08/24 10:18
Starling Oncology Institute Secures New $25 Million Credit Facility
TipRanks · 08/21 21:58
Oncology Institute Earnings Call Highlights Growth And Risks
TipRanks · 08/20 00:12
Major Investor Quietly Ramps Up Stake in Starling Oncology Institute
TipRanks · 08/18 02:08
Weekly Report: what happened at STLN last week (0810-0814)?
Weekly Report · 08/17 10:19
Weekly Report: what happened at STLN last week (0803-0807)?
Weekly Report · 08/10 10:14
Starling Oncology Q2 EPS $(0.08) Up From $(0.15) YoY, Sales $161.282M Up From $119.802M YoY
Benzinga · 08/07 17:48
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 08/07 17:05
More
Webull provides a variety of real-time STLN stock news. You can receive the latest news about Starling Oncology, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About STLN
Starling Oncology, Inc., formerly The Oncology Institute, Inc., is advancing oncology by delivering specialized, value-based cancer care in the community setting. The Company offers cutting-edge, evidence-based cancer care to a population of approximately 2.1 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with oncology organizations. Its critical services include cancer treatment and infusion centers, in-house dispensary, lab testing, outpatient blood transfusion, financial counseling, end-of-life counseling and comprehensive clinical trials. It treats many forms of cancer, including Acute lymphoblastic leukemia; Acute myeloid leukemia; Bladder cancer; Bone cancer; Brain cancer; Cervical cancer; Choriocarcinoma; Chronic lymphocytic leukemia (CLL); Chronic myeloid leukemia (CML); Skin cancer, and others. It operates over 100 clinics and affiliate locations across multiple states.